ZYDUS PHARMACEUTICALS UK LTD
Get an alert when ZYDUS PHARMACEUTICALS UK LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-10-05 (in 5mo)
Last made up 2025-09-21
Watchouts
None on the register
Cash
£5M
Latest balance sheet
Net assets
£65M
Equity attributable
Employees
97
Average over period
Profit before tax
-£2M
Period ending 2025-03-31
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · latest reflected 2025-03-31
| Metric | Trend | 2023-02-07 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|
| Turnover | — | £5,597,300 | £23,508,729 | |
| Operating profit | — | -£2,866,909 | £4,037,385 | |
| Profit before tax | — | -£5,181,741 | -£2,008,598 | |
| Net profit | — | £63,378 | -£4,769,070 | |
| Cash | — | £1,711,757 | £5,133,258 | |
| Total assets less current liabilities | — | £169,119,576 | £140,299,878 | |
| Net assets | — | £69,963,378 | £65,194,308 | |
| Equity | — | £69,963,378 | £65,194,308 | |
| Average employees | — | 97 | 97 | |
| Wages | — | £1,604,369 | £4,303,864 | |
| Directors' remuneration | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-02-07 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|
| Operating margin | — | -51.2% | 17.2% | |
| Net margin | — | 1.1% | -20.3% | |
| Return on capital employed | — | -1.7% | 2.9% | |
| Gearing (liabilities / total assets) | — | 59.9% | 62.9% | |
| Current ratio | — | 2.64x | 0.61x | |
| Interest cover | — | -1.22x | 0.67x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- The Corporate Practice Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group and parent company's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.”
Group structure
- ZYDUS PHARMACEUTICALS UK LTD · parent
- LM Manufacturing Limited 100%
- Liqmeds Lifecare Limited 100%
- Liqmeds Limited 100%
- Liqmeds Worldwide Limited 100%
- Medsolutions (Europe) Limited 100%
- LM manufacturing India Private Limited 99.8%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| VISTRA COSEC LIMITED | Corporate Secretary | 2023-02-08 | — | — |
| DIWAKAR, Naik Amrut | Director | 2023-02-08 | Sep 1975 | Indian |
| MONAPPA, Akhil Arun | Director | 2023-02-08 | Sep 1978 | Indian |
| PATEL, Kamlesh Kanubhai | Director | 2023-02-08 | Nov 1958 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Pankaj Ramanbhai Patel | Individual | ownership-of-shares-50-to-75-percent-as-trust, voting-rights-50-to-75-percent-as-trust, right-to-appoint-and-remove-directors-as-trust | 2023-02-08 | Active |
| Mrs Pritiben Pankajbh Patel | Individual | ownership-of-shares-50-to-75-percent-as-trust, voting-rights-50-to-75-percent-as-trust, right-to-appoint-and-remove-directors-as-trust | 2023-02-08 | Active |
| Dr Sharvil Pankajbhai Patel | Individual | ownership-of-shares-50-to-75-percent-as-trust, voting-rights-50-to-75-percent-as-trust, right-to-appoint-and-remove-directors-as-trust | 2023-02-08 | Active |
Filing timeline
Last 14 of 14 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-20 | CH04 | officers | Change corporate secretary company with change date | |
| 2026-03-02 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-10-13 | AA | accounts | Accounts with accounts type group | |
| 2025-10-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-07 | AA | accounts | Accounts with accounts type group | |
| 2025-02-27 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-02-13 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-11-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-01 | SH01 | capital | Capital allotment shares | |
| 2023-09-21 | SH01 | capital | Capital allotment shares | |
| 2023-09-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-02-10 | CH01 | officers | Change person director company with change date | |
| 2023-02-09 | AA01 | accounts | Change account reference date company current extended | |
| 2023-02-08 | NEWINC | incorporation | Incorporation company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.